The Journal of Pediatrics
Volume 150, Issue 4 , Pages 358-363, April 2007

Ontogeny of Salivary Epidermal Growth Factor and Necrotizing Enterocolitis

Division of Neonatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; Good Samaritan Hospital, TriHealth, Cincinnati, Ohio; the Division of Pediatric General and Thoracic Surgery, Cincinnati Children’s Hospital, Cincinnati, Ohio; and the Institute for the Study of Health, University of Cincinnati Medical Center, Cincinnati, Ohio.

Received 21 June 2006; received in revised form 5 October 2006; accepted 21 November 2006.

Objective

To examine the ontogeny of salivary epidermal growth factor (sEGF) in premature infants and to determine the relation of sEGF to the development of necrotizing enterocolitis (NEC).

Study design

Salivary EGF was prospectively measured in 327 infants with gestational ages from 23 weeks to term. Infants of ⩽32 weeks’ gestation (n = 261) were followed with weekly sEGF measurements through 3 weeks of life. Multivariable regression analyses were used to determine variables significantly related to sEGF levels and to identify predictors of NEC.

Results

Over the first 3 weeks of life, sEGF increased across gestational age and postnatal age categories. In multivariable models, gestational age was a significant predictor of sEGF levels (P < .009). In a cohort of 27 infants who had NEC, gestational age, race, and changes in sEGF levels between weeks of life 1 and 2 were predictive of the development of NEC. These infants had lower sEGF at week 1 and greater increases from week 1 to week 2 compared with infants without NEC.

Conclusions

There is a positive relation between sEGF levels and gestational age. Patterns of sEGF levels over the first 2 weeks of life were significantly related to development of NEC in very low birth weight infants.

Abbreviations: DOL, Day of life, EGFR, Epidermal growth factor receptor, NEC, Necrotizing enterocolitis, sEGF, Salivary epidermal growth factor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (RO3 DK61596-02).

PII: S0022-3476(06)01126-7

doi:10.1016/j.jpeds.2006.11.059

Refers to article:

  • Is EGF the Holy Grail for NEC?

    Michael Caplan
    The Journal of Pediatrics April 2007 (Vol. 150, Issue 4, Pages 329-330)

The Journal of Pediatrics
Volume 150, Issue 4 , Pages 358-363, April 2007